髓系白血病
生物
祖细胞
计算生物学
髓样
癌症研究
白血病
表型
造血
单细胞测序
干细胞
基因
遗传学
外显子组测序
作者
Junqing Wu,Yanyu Xiao,Jie Sun,Huiyu Sun,Haide Chen,Yuanyuan Zhu,Huarui Fu,Chengxuan Yu,E Weigao,Shujing Lai,Lifeng Ma,Jiaqi Li,Lijiang Fei,Mengmeng Jiang,Jingjing Wang,Fang Ye,Renying Wang,Ziming Zhou,Guodong Zhang,Tingyue Zhang
标识
DOI:10.1186/s13045-020-00941-y
摘要
Abstract Background Acute myeloid leukemia (AML) is a fatal hematopoietic malignancy and has a prognosis that varies with its genetic complexity. However, there has been no appropriate integrative analysis on the hierarchy of different AML subtypes. Methods Using Microwell-seq, a high-throughput single-cell mRNA sequencing platform, we analyzed the cellular hierarchy of bone marrow samples from 40 patients and 3 healthy donors. We also used single-cell single-molecule real-time (SMRT) sequencing to investigate the clonal heterogeneity of AML cells. Results From the integrative analysis of 191727 AML cells, we established a single-cell AML landscape and identified an AML progenitor cell cluster with novel AML markers. Patients with ribosomal protein high progenitor cells had a low remission rate. We deduced two types of AML with diverse clinical outcomes. We traced mitochondrial mutations in the AML landscape by combining Microwell-seq with SMRT sequencing. We propose the existence of a phenotypic “cancer attractor” that might help to define a common phenotype for AML progenitor cells. Finally, we explored the potential drug targets by making comparisons between the AML landscape and the Human Cell Landscape. Conclusions We identified a key AML progenitor cell cluster. A high ribosomal protein gene level indicates the poor prognosis. We deduced two types of AML and explored the potential drug targets. Our results suggest the existence of a cancer attractor.
科研通智能强力驱动
Strongly Powered by AbleSci AI